Covered recipient · General Payments record
KATINA D HALL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$301.72
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.54 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $37.98 | 2 |
| PFIZER INC. | $34.53 | 2 |
| ABBVIE INC. | $27.78 | 1 |
| Acerta Pharma LLC | $21.41 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.02 | 1 |
| Exact Sciences Corporation | $18.35 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.04 | 1 |
| Novo Nordisk AS | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.78 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107276220 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.41 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105631713 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.02 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086347723 | CMS |
| Exact Sciences Corporation | $18.35 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114440036 | CMS |
| Lilly USA, LLC | $17.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135766635 | CMS |
| Lilly USA, LLC | $20.70 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135766251 | CMS |
| Novo Nordisk Inc | $15.43 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100648657 | CMS |
| PFIZER INC. | $13.49 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131499118 | CMS |
| PFIZER INC. | $21.04 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132004364 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.04 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151171230 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.